Jonathan CP Roos (PMFA)

Harvard, Cambridge & Moorfields-trained Consultant Oculoplastic Surgeon and academic based in London at www.FaceRestoration.com. Publishes in the world’s leading medical journals and lectures internationally on aesthetics, eyelid diseases and thyroid eyes.

JOURNAL REVIEWED: New England Journal of Medicine | Ophthalmic Epidemiology

Latest Contribution

Meibomian gland alteration in patients with primary chronic dacryocystitis: An in vivo confocal microscopy study

1 October 2015 | | Oculoplastics, Orbit | Confocal microscopy, meibomian gland, primary chronic dacryocystitis

Chronic dacryocystitis affects tear film functionality and can predispose to ocular surface disease, however the specific effect of chronic dacryocystitis on meibomian gland function has not been studied. This group therefore performed in vivo confocal microscopy in 28 patients’ eyes...

Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma single institutional experience

1 October 2015 | | Oculoplastics, Orbit | Extranodal marginal zone lymphoma, Rituximab, immunotherapy, lymphoma, ocular adnexa

Ocular adnexal lymphomas constitute 2% of all non-Hodgkin’s disease and 5-15% of all extranodal lymphomas and are usually localised, low-grade and of B-cell origin. This opens them up to potential treatment with a systemic monoclonal antibody-based drug (rituximab) directed at...

Lower postoperative scar height is associated with increased postoperative trichiasis one year after bilamellar tarsal rotation surgery

1 October 2015 | | Oculoplastics, Orbit | Bilamellar tarsal rotation, incision height, postoperative trichiasis, trachoma, trichiasis

Bilamellar tarsal rotation has been a key component of the WHO SAFE approach to blindness from trichiaisis (surgery, antibiotics, facial hygiene, environment). The World Health Organisation (WHO) manual describes the procedure as a full thickness blepharotomy placed 3.0mm above and...